Ajinomoto Bio-Pharma Services introduces a new global brand identity to emphasize its specialized contract development and manufacturing capabilities within the pharmaceutical sector.
Ajinomoto Bio-Pharma Services, a subsidiary of Ajinomoto Co., unveiled a refreshed global brand, which is unlikely to have a material financial impact.
Ajinomoto Bio-Pharma Services, a subsidiary of Ajinomoto Co., has launched a refreshed global brand identity. The move aims to highlight the company's expertise in navigating complex pharmaceutical development and manufacturing challenges for its global client base.
The refresh is intended to better reflect the company's depth of expertise and innovation in supporting pharmaceutical development and manufacturing clients.